Sicart Associates LLC Alkermes Plc. Transaction History

Sicart Associates LLC

  • $272 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019
SELL
$27.94 - $44.61 $349,250 - $557,625
-12,500 Closed
0 $0
Q4 2017

Jan 17, 2018
SELL
$47.69 - $55.39 $309,985 - $360,035
-6,500 Closed
0 $0
Q3 2017

Nov 06, 2017
BUY
$49.16 - $54.45 $319,540 - $353,925
6,500
6,500 $330,000

Others Institutions Holding ALKS

# of Institutions
363
Shares Held
182M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.05B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Sicart Associates LLC Portfolio

Follow Sicart Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email